Indication
Biotherapy
1 clinical trial
1 product
2 drugs
Clinical trial
Multicentre, Randomized, Multi-arm Trial Comparing the Efficacy and Safety of Adalimumab, Anakinra and Tocilizumab in Subjects With Non-infectious Refractory Uveitis RUBI: Refractory Uveitis BIotherapiesStatus: Completed, Estimated PCD: 2021-10-29
Product
AnakinraDrug
TocilizumabDrug
Adalimumab